 | | - Save the date - 2024 Survivorship Symposium!
- Get your Move-A-Thon t-shirts (we might be biased, but we think they look great)
- Register your screening event now in order to get your host site kit in time!
- Meet our newest Ambassador, Eva Grayzel
- News & Shorts
|
| |
|
|
|
| | Get your calendars pulled up and save the date for this year's Survivorship Symposium! On October 5th, we'll be heading to the City of Brotherly Love, and hope to have you join us!
Just like last year, this event will be happening in person and also virtually (for those unable to get to Philadelphia). Join the staff and board of the Alliance, fellow patients, survivors, caregivers, and clinicians as we meet and learn from each other.
We're working on all the details now and will share more in the coming months! So brush up on your American Revolution history and re-watch Rocky - we're going to Philly! |
|
|
| | | HEAD & NECK CANCER AWARENESS MONTH - APRIL |
| |
|
| | MOVE-A-THON SHIRTS ARE HERE! Show your support of the Move-A-Thon and the Alliance by purchasing this year's t-shirt (sweatshirts also available). We have many colors and sizes available, and shirts should arrive in about a week. As a reminder, the Move-A-Thon is our annual fundraising event held in April. We invite you to sign up and join us by moving your way according to your interests and ability (you decide - it could be running, walking, playing with your kids - whatever you feel capable of doing).
Then, during Head and Neck Cancer Awareness Month, join us in moving and raising funds and awareness. Find out more here!
|
|
|
HEALTHCARE PROFESSIONALS - STILL TIME TO REGISTER YOUR EVENT! Our host site kits are being sent out now, but there's still time to register your screening with us and receive your kit (for events in the US).
Let's partner together and spread awareness! We make it easy for your organization to participate by providing volunteer t-shirts, educational materials, and customizable posters free of charge, and you organize the staff and volunteers.
We also welcome registrations for head and neck cancer screenings throughout the year - your event does not have to be during Head and Neck Cancer Awareness Month. We'll still provide the host site kits for your event. Just fill out the form below! |
|
|
| | | MEET OUR NEWEST AMBASSADOR:
Eva Grayzel
Greenwood, Indiana
Survivor of Salivary Duct Carcinoma |
| Eva, a professional interactive performance artist, was diagnosed with late-stage oral cancer at age 33. A non-smoker, she was bounced among dental professionals while the ulcer on her tongue grew more prominent and painful. “My first biopsy was misread by a general pathologist as hyperkeratosis, when in fact it was moderate dysplasia which had a chance of turning into cancer,” explained Eva. “I didn’t know there were specialists in pathology, nor did I know that biopsies are not 100% definitive. It was two years and nine months from the first biopsy until the day I was finally diagnosed with late-stage oral cancer,” explained Eva. “During that time, bouncing back and forth between my dental practice and oral surgeons, no one EVER mentioned the words ‘oral cancer’ as a possible cause.” “I share my personal story hoping it will inspire dental and healthcare professionals to raise the bar on patient education and the early signs of oral cancer. It’s more than my mission to educate. It’s my tribute to all those who came before me and my obligation to those who will follow,” added Eva. To read Eva's full story, please click the button to the right. |
|
|
| | |
|
|  | Save the date for our next webinar - May 23rd
Head and Neck Cancer: What To Expect the First Year A head and neck cancer diagnosis is daunting, and the initial year of treatment has its challenges. To help you navigate through this initial year, leading medical experts, a HNCA Ambassador survivor and caregiver will share their insights and experiences to assist patients and caregivers facing the initial months of the head and neck cancer journey.
Registration and more details available soon! |
|
|
 | Our friends at FLASCO are hosting a free educational program for patients and caregivers to learn and exchange information regarding a Nasopharyngeal Cancer (NPC) diagnosis. They will bring together Oncology Experts, Advocacy Groups, Community Support Groups, and Industry Representatives to empower patients with the information and resources needed to navigate a cancer diagnosis, become their own advocates and to live an enhanced quality of life. Find out more here |
|
|
| | NEWS STORY: Low-Dose Radiation To Treat HPV Throat Cancer a ‘Game Changer’
An innovative radiation treatment approach is dramatically improving quality of life for most people with throat cancer and other head and neck cancers caused by the human papillomavirus (HPV). The new method, pioneered by Memorial Sloan Kettering Cancer Center (MSK) radiation oncologist Nancy Lee, MD, greatly reduces the radiation dose to minimize side effects.
NEWS STORY: Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9
Merck today, at the EUROGIN 2024 HPV Congress, announced plans to initiate clinical development of a new investigational multi-valent HPV vaccine designed to provide broader protection against multiple HPV types. Separately, the company also plans to conduct clinical trials in both females and males to evaluate the efficacy and safety of a single-dose regimen of GARDASIL®9 (Human Papillomavirus 9-valent, recombinant), compared to the approved three-dose regimen. NEWS STORY: HPV-Associated Oropharyngeal Cancer: Intratreatment FDG-PET Response as a Biomarker for De-escalation of Radiotherapy
The use of imaging midtreatment for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma may guide the use of deintensified chemoradiotherapy, according to a phase II study from the University of Michigan presented by Regan et al at the 2024 Multidisciplinary Head and Neck Cancers Symposium. NEWS STORY: APG-115 Produces Encouraging Disease Control in p53 Wild-Type Salivary Gland Cancer
A high rate of disease control was seen with the novel MDM2 inhibitor APG-115-alrizomadlin (APG-115) in patients with p53 wild-type salivary gland cancer, including those with adenoid cystic carcinoma (ACC), according to data from a phase 1/2 trial that were presented during the 2024 Multidisciplinary Head and Neck Cancers Symposium. |
|
|
| | FRIENDS HOSTING FUNDRAISERS |
|
|
| | RAISE A GLASS - ORLANDO
This event held in Orlando, FL allows you to add a name to a car wrap which honors patients, survivors, caregivers, nurses, doctors who are making a difference in the lives of those affected by cancer.
You can add the name of any person impacted by cancer (regardless of the type of cancer)!
Find out more here |
|
|
HONORING BRIAN ROBERTS "Honoring Brian" is a collaboration brew to honor Mad Science Brewing owner, Brian Roberts. Brian is currently undergoing treatment for head and neck cancer, and this fundraiser is in support of Head & Neck Cancer Alliance at his request. Brian would like to spread the word about the Alliance's mission and to help care for those affected and better yet help prevent it altogether.
Make a donation here |
|
|
SMASH CANCER TENNIS TOURNEY The Smash Cancer Tournament (now in its 15th year) raises funds and awareness for head and neck cancer. During the tournament, physicians and clinical staff will perform free screenings for head and neck cancer and provide educational materials to the public. Thanks to the sponsors and participants they have been able to donate over $150,000 to the Alliance to date.
Find out more about Smash Cancer |
|
|
|
|
| | DO YOU FOLLOW? Are you following us on social media? It's just one more way to keep up to date with what is going on with us as well as other head and neck cancer related news and opportunities. So pick your favorite platform and give us a follow!
Facebook | Twitter* | LinkedIn | Instagram
*also known as X
|
|
|
| | | | | Thank You to our Corporate Partners |
| | | |
|
| | | *Statement on Sponsor Content and Corporate Support: The information published on this website and in our materials is intended to educate you about Oral, Head and Neck Cancer. The content is not intended to take the place of a discussion with a qualified physician who is familiar with your medical situation. It is important to remember that each individual is different, and the reasons for—and outcomes of—any treatment plan depends on the patient's individual condition. If you have questions or concerns after reading any information on this website or in our materials, you should discuss them openly and honestly with your physician. Any products and manufacturers included on this site are presented for informational purposes only and do not constitute product approval or endorsement by HNCA. The content provided by HNCA is in no way intended to be a substitute for medical consultation with a qualified professional. HNCA encourages those using its resources to be careful when evaluating medical information or products. If you are unsure about your medical condition, consult a physician. Funding from our corporate partners supports HNCA’s programs and educational initiatives, and HNCA maintains independence in its design of programs, content, and initiatives. |
| | Head and Neck Cancer Alliance
PO BOX 21688 | Charleston, South Carolina 29413
866-792-4622 | hello@headandneck.org |
| | Be sure to add our email address to your address book or safe senders list so our emails get to your inbox. Having trouble viewing this email? View it in your web browser |
|
|
| Head and Neck Cancer Alliance
PO BOX 21688 | Charleston, South Carolina 29413
866-792-4622 | hello@headandneck.org |
| | |
|
| |
|
|
